Personnel change in the Klinik Linde management

Serge Reichlin (52) has managed Klinik Linde since 2018. Prior to joining Hirslanden, the qualified specialist in internal medicine worked as the Head of Managerial Services at University Hospital Basel. In that role, he was jointly responsible for the strategic development of the University Hospital.

Together with his team, Serge Reichlin has successfully promoted the integration of Klinik Linde, which joined the Hirslanden Group in 2017. In doing so, he has positioned Linde as the leading private hospital in the Biel-Seeland-Berner Jura region. Klinik Linde offers first-class primary care and focuses on specific medical specialties.

Serge Reichlin, born and resident in Basel, will become CEO of Klinik Barmelweid, a leading specialist and rehabilitation hospital in north-western Switzerland, as of 1 May 2021. The appointment of Serge Reichlin further strengthens the existing cooperation between Klinik Barmelweid and Hirslanden.

Stefanie Ruckstuhl (33), the new Hospital Manager of Klinik Linde from 1 April, joined the Hirslanden Group in 2017 in the field of Business Development. In this role, she was responsible for various Group-wide initiatives with a high strategic relevance. Since July 2019, she has been in charge of Strategy Development & Business Development, Management Cycle and the Project Management Office as Head of Corporate Development & Innovation at the Hirslanden Group. Prior to Hirslanden, Stefanie Ruckstuhl worked for over five years at the consulting firm KPMG and was a member of the Healthcare Advisory Leadership Team.

Stefanie Ruckstuhl studied business administration and recently completed an Executive MBA from the University of St. Gallen (HSG). Due to her previous professional positions, she has in-depth knowledge of the Swiss healthcare system and extensive management experience. She is familiar with the city of Biel from previous projects at KPMG. She will already be spending some of her time on site at Klinik Linde in the coming months in order to ensure a smooth transition of the hospital management

The Executive Committee of the Hirslanden Group would like to thank Serge Reichlin for his outstanding achievements as Hospital Manager of Klinik Linde and wish him all the best in his new job. The Executive Committee also welcomes Stefanie Ruckstuhl in her new role and wishes her every success. "We are very pleased that, in Stefanie Ruckstuhl, we have found a highly qualified candidate from our own ranks to take on this position and that we are able to offer our employees interesting career models within the company," says Stéphan Studer, COO West of the Hirslanden Group.
 

About Hirslanden

The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 4 outpatient surgical units, 17 radiology institutes and 5 radiotherapy institutes. Together with public and private cooperation partners, Hirslanden focuses on the continuum of care, promoting high-quality, responsible, personalised and efficiently integrated healthcare. The Group has 2,506 affiliated doctors and 10,417 employees, of whom 498 are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2019/20 financial year, the Group generated turnover of CHF 1,804 million. As at 31.3.2020, the Group had treated 107,491 patients, amounting to a total of 471,717 inpatient days. In insurance terms, the patient mix consists of 49.2% basic, 29.3% semi-private, and 21.5% private insured patients.

Hirslanden is synonymous with first-class medical care provided by highly qualified medical specialists with many years of experience. As a system provider, the Group stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007 it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.